Dysgonic fermenter 2 (DF-2) is a fastidious, gram-negative organism well recognized as a cause of fulminant septicemia in patients without spleens or patients with alcoholic cirrhosis. In vitro antibiotic susceptibility testing of eight strains with a Schaedler broth dilution technique revealed DF-2 to be susceptible to all of the antibiotics tested except aztreonam. Previous reports that DF-2 is aminoglycoside resistant were based on disk diffusion or agar dilution assays that may be less reliable given the slow growth of the organism and its requirement for CO2 incubation. Penicillin is commonly used as prophylaxis after dog bites and has excellent activity against DF-2.
Dysgonic fermenter 2 (DF-2) is a recognized cause of serious infection following dog bites in splenectomized patients or patients with liver cirrhosis (1, 7) . The clinical picture of splenectomized patients can be one of fulminant septicemia and disseminated intravascular coagulation; examination of the buffy coat of blood has revealed the organism in several cases. The mortality of infection with DF-2 is about 25% (7) .
The organism is fastidious in its growth requirements, and systematic studies on antibiotic susceptibilities using several strains have not been performed. We tested MICs and MBCs of various antibiotics for eight strains of DF-2 with a Schaedler broth dilution method to develop recommendations on appropriate agents for therapy of DF-2 infections. tion and plating of samples from the broth at 24-h intervals) were lower than when Schaedler broth was used. An inoculum of 107 CFU or greater was necessary to sustain growth consistently in Schaedler broth. The inoculum was prepared from a 72-h growth on chocolate agar and suspended in Schaedler broth. A barium sulfate standard was used to produce a stock concentration of 1.5 x 108 CFU/ml, from which a 10-fold dilution was made. Each tube contained 1 ml of DF-2 suspension (1.5 x 107/ml) and 1 ml of broth; the final concentration of DF-2 in each tube was 0.75 x 107/ml (confirmed by serial dilution and plating). The MIC was defined as the lowest concentration of antibiotic that inhibited visible growth in Schaedler broth after 72 h of incubation in 5% CO2 at 35°C. The MBC, determined by plating of 0.025 ml from clear tubes onto chocolate agar, was defined as the lowest concentration at which fewer than five colonies of DF-2 grew.
MATERIALS AND METHODS
Experiments were performed to study the effect of Schaedler broth and prolonged CO2 incubation on antimicrobial agent activity. Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 27853) were used, and susceptibility testing was performed as described above, except that the final concentration of bacteria per tube was 2.0 x 105 CFU/ml in (i) Mueller-Hinton broth, (ii) Schaedler broth, and (iii) Schaedler broth to which the antimicrobial agents were added and allowed to incubate in CO2 for 48 h. The bacterial inoculum was then added, and the tubes were incubated in CO2 for another 24 h.
RESULTS
Results of experiments comparing Mueller-Hinton broth with Schaedler broth with and without CO2 incubation using sheep blood agar plates and found no zones of inhibition with methicillin, gentamicin, and kanamycin in the two strains tested. Waters et al. (11) and Hinrichs and Dunkelberg (8) , also using a disk diffusion method, found their DF-2 strain to be aminoglycoside resistant (4).
Our study used a broth (as opposed to agar) dilution method with Schaedler broth. In contrast to previous reports, we found all DF-2 strains to be susceptible to the aminoglycosides. Additional experiments were performed to confirm this finding. Cation supplementation of the Schaedler broth did not alter our results; this was done because calcium and magnesium are known to affect the susceptibility of Pseudomonas species to aminoglycosides (3) . No zones of inhibition were noted around the aminoglycosides on Kirby-Bauer disk diffusion assay (although we did note heterotypic resistance). Disk diffusion assays are probably unreliable for testing of DF-2, since the time of incubation (3 to 5 days) and the conditions of incubation (CO2 environment) are not standard. Cooper's theory of critical time (2) (one of the basic concepts of disk diffusion susceptibility testing) states that a certain time is required for the inoculum to reach a critical density, after which it grows in concentrations of the antibiotics many times the MIC for the organism. The critical time for most organisms is 2 to 6 h of incubation but is much longer for a slow-growing organism like DF-2. Several investigators have shown that incubation in CO2 causes a fall in the pH of the medium and decreases the zone size and increases the MICs (for organisms other than DF-2) of the aminoglycosides (5, 9). Therefore, CO2 incubation is not desirable for routine susceptibility testing. When CO2 incubation is unavoidable (as with DF-2), then broth dilution methods are probably superior since there is less surface area in contact with the atmospheric CO2 than is the case with the agar dilution or diffusion method. Our comparison of Mueller-Hinton broth with Schaedler broth and CO2 incubation (using three nonfastidious organisms) revealed increased amikacin, but not tobramycin or gentamicin, MICs as a result of CO2 incubation. Other antibiotics whose MICs were raised by CO2 incubation in Schaedler medium were vancomycin, erythromycin, trimethoprim, piperacillin, and imipenem. With the exception of imipenem, piperacillin, and trimethoprim, the increased MICs were a matter of 1 tube dilution, which is often regarded as within the linlits of experimental error (6) . Despite the technique we used (which could have made DF-2 appear resistant), all DF-2 strains tested were susceptible to the aminoglycosides.
In a patient with fulminant septicemia following a dog bite, DF-2 should be strongly suspected. Examination of a Gram stain of the buffy coat, always of value in patients with splenectomy, is particularly useful in DF-2 infections, since the organism grows slowly and several days may pass before it is identified by the microbiology laboratory (7) . DF-2 is susceptible to most antibiotics (with the exception of aztreonam) in vitro when measured by a broth dilution technique, and penicillin appears to be the drug of choice, with numerous other acceptable alternatives. Prompt therapy for established cases, prophylaxis for dog bite wounds (especially in high-risk individuals), and increasing awareness of DF-2 may decrease the morbidity and mortality from infections with this organism.
